{"transactions":[{"id":762613,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-27T23:28:36.000Z","date":"2026-05-27","kind":"sale","planned":false,"acquired":false,"shares":23145,"price":86.4201,"value":2000193.2145,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98611,"source":{"system":"sec-edgar","filing":"0001225208-26-005610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005610/doc4.xml","form_type":"4"}},{"id":775716,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-18T21:28:28.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":8000,"price":81.8216,"value":654572.8,"ownership":{"direct":false,"nature":"401(k)"},"balance_after":30969.5756,"source":{"system":"sec-edgar","filing":"0001225208-26-005463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005463/doc4.xml","form_type":"4"}},{"id":775715,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-18T21:28:28.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":9968,"price":82.0732,"value":818105.6576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22798.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005463/doc4.xml","form_type":"4"}},{"id":783152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2026-05-12T20:52:39.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":13457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":13457},"source":{"system":"sec-edgar","filing":"0001225208-26-005171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005171/doc4.xml","form_type":"4"}},{"id":783151,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-12T20:52:39.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":7469,"price":79.96,"value":597221.24,"ownership":{"direct":true},"balance_after":32766.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005171/doc4.xml","form_type":"4"}},{"id":783150,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-12T20:52:39.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":13457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":40235.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005171/doc4.xml","form_type":"4"}},{"id":787486,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":7850,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":7850},"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787485,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":44000,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787484,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1038,"price":82.76,"value":85904.88,"ownership":{"direct":true},"balance_after":26778.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787483,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":83.2,"value":69139.2,"ownership":{"direct":true},"balance_after":27816.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787482,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":28647.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":794449,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-04T23:29:44.000Z","date":"2026-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":469,"price":83.98,"value":39386.62,"ownership":{"direct":true},"balance_after":20797.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-004907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004907/doc4.xml","form_type":"4"}},{"id":821069,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-04-02T21:13:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":22680,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":59.2567,"exercise_date":"2019-06-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":22680},"source":{"system":"sec-edgar","filing":"0001225208-26-004249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004249/doc4.xml","form_type":"4"}},{"id":821068,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-04-02T21:13:52.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":18004,"price":80.0494,"value":1441209.3976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $79.490 to $80.435. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21266.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004249/doc4.xml","form_type":"4"}},{"id":821067,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-04-02T21:13:52.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":4676,"price":80.5915,"value":376845.854,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $80.510 to $80.660. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39270.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004249/doc4.xml","form_type":"4"}},{"id":821066,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-04-02T21:13:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":22680,"price":59.2567,"value":1343941.956,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."}],"balance_after":43946.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-004249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004249/doc4.xml","form_type":"4"}},{"id":875202,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-03-02T22:50:44.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":11340,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22680,"derivative":{"exercise_price":59.2567,"exercise_date":"2019-06-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":11340},"source":{"system":"sec-edgar","filing":"0001225208-26-002878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826002878/doc4.xml","form_type":"4"}},{"id":875201,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-03-02T22:50:44.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":11340,"price":85.9286,"value":974430.324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $85.665 to $86.380. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21266.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-002878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826002878/doc4.xml","form_type":"4"}},{"id":875200,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-03-02T22:50:44.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":11340,"price":59.2567,"value":671970.978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."}],"balance_after":32606.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-002878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826002878/doc4.xml","form_type":"4"}},{"id":880336,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-02-27T00:33:53.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":24000,"price":83.8365,"value":2012076.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $83.66 to $83.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total reflects the correction of 13,396 shares held indirectly by the Reporting Person's trust, which were previously reported as directly held."}],"balance_after":21266.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-002711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826002711/doc4.xml","form_type":"4"}},{"id":948223,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-01-06T23:02:00.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":11340,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34020,"derivative":{"exercise_price":59.2567,"exercise_date":"2019-06-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":11340},"source":{"system":"sec-edgar","filing":"0001225208-26-000378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000378/doc4.xml","form_type":"4"}},{"id":948222,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-01-06T23:02:00.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":8708,"price":85.9793,"value":748707.7444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $85.40 to $86.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31870.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-000378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000378/doc4.xml","form_type":"4"}},{"id":948221,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-01-06T23:02:00.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":2632,"price":84.6206,"value":222721.4192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.39 to $85.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":40578.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-000378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000378/doc4.xml","form_type":"4"}},{"id":948220,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-01-06T23:02:00.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":11340,"price":59.2567,"value":671970.978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."}],"balance_after":43210.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-000378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826000378/doc4.xml","form_type":"4"}},{"id":971861,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-12-12T22:57:48.000Z","date":"2025-12-12","kind":"gift","planned":false,"acquired":false,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31870.2532,"source":{"system":"sec-edgar","filing":"0001225208-25-009935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009935/doc4.xml","form_type":"4"}},{"id":971860,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-12-12T22:57:48.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":5900,"price":83.74,"value":494066.0,"ownership":{"direct":true},"balance_after":38970.2532,"source":{"system":"sec-edgar","filing":"0001225208-25-009935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009935/doc4.xml","form_type":"4"}},{"id":971859,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-12-12T22:57:48.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":5486.1175,"price":83.79,"value":459681.785325,"ownership":{"direct":true},"balance_after":44870.2532,"source":{"system":"sec-edgar","filing":"0001225208-25-009935","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009935/doc4.xml","form_type":"4"}},{"id":975107,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-12-10T23:58:45.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":false,"shares":11340,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45360,"derivative":{"exercise_price":59.2567,"exercise_date":"2019-06-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":11340},"source":{"system":"sec-edgar","filing":"0001225208-25-009841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009841/doc4.xml","form_type":"4"}},{"id":975106,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:45.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":11340,"price":83.8255,"value":950581.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.465 to $84.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50356.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-009841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009841/doc4.xml","form_type":"4"}},{"id":975105,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:45.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":true,"shares":11340,"price":59.2567,"value":671970.978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."}],"balance_after":61696.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-009841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009841/doc4.xml","form_type":"4"}},{"id":1128256,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-06-02T21:01:58.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":2570,"price":77.3974,"value":198911.318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.36 to $77.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50356.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-005628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005628/doc4.xml","form_type":"4"}},{"id":1152755,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-05-12T23:30:36.000Z","date":"2025-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":816,"price":73.68,"value":60122.88,"ownership":{"direct":true},"balance_after":52926.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004999/doc4.xml","form_type":"4"}},{"id":1154289,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2025-05-09T23:33:08.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":8375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":8375,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":8375},"source":{"system":"sec-edgar","filing":"0001225208-25-004939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004939/doc4.xml","form_type":"4"}},{"id":1154288,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:33:08.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":47000,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001225208-25-004939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004939/doc4.xml","form_type":"4"}},{"id":1154287,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-05-09T23:33:08.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":8375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":53742.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004939/doc4.xml","form_type":"4"}},{"id":1154286,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-05-09T23:33:08.000Z","date":"2025-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":851,"price":74.92,"value":63756.92,"ownership":{"direct":true},"balance_after":45367.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004939/doc4.xml","form_type":"4"}},{"id":1159949,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-05-05T23:29:27.000Z","date":"2025-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":508,"price":75.65,"value":38430.2,"ownership":{"direct":true},"balance_after":46218.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004766/doc4.xml","form_type":"4"}},{"id":1159948,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-05-05T23:29:27.000Z","date":"2025-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":480,"price":75.65,"value":36312.0,"ownership":{"direct":true},"balance_after":46726.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004766/doc4.xml","form_type":"4"}},{"id":1172922,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-04-14T22:18:21.000Z","date":"2025-04-14","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001225208-25-004230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004230/doc4.xml","form_type":"4"}},{"id":1172921,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-04-14T22:18:21.000Z","date":"2025-04-14","kind":"sale","planned":true,"acquired":false,"shares":9500,"price":69.8101,"value":663195.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $69.48 to $70.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47206.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004230/doc4.xml","form_type":"4"}},{"id":1172920,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-04-14T22:18:21.000Z","date":"2025-04-14","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":45.2767,"value":430128.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":56706.3707,"source":{"system":"sec-edgar","filing":"0001225208-25-004230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004230/doc4.xml","form_type":"4"}},{"id":1208292,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-03-13T21:41:54.000Z","date":"2025-03-13","kind":"exercise","planned":true,"acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001225208-25-003388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003388/doc4.xml","form_type":"4"}},{"id":1208291,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-03-13T21:41:54.000Z","date":"2025-03-13","kind":"sale","planned":true,"acquired":false,"shares":9500,"price":67.9604,"value":645623.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $67.55 to $68.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-003388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003388/doc4.xml","form_type":"4"}},{"id":1208290,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-03-13T21:41:54.000Z","date":"2025-03-13","kind":"exercise","planned":true,"acquired":true,"shares":9500,"price":45.2767,"value":430128.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":56435.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-003388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003388/doc4.xml","form_type":"4"}},{"id":1270149,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-02-13T23:04:19.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19000,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001225208-25-001711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001711/doc4.xml","form_type":"4"}},{"id":1270148,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:19.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":6400,"price":75.7402,"value":484737.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.19 to $76.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-001711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001711/doc4.xml","form_type":"4"}},{"id":1270147,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:19.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":100,"price":76.26,"value":7626.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":53335.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-001711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001711/doc4.xml","form_type":"4"}},{"id":1270146,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-02-13T23:04:19.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":6500,"price":45.2767,"value":294298.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":53435.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-001711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825001711/doc4.xml","form_type":"4"}},{"id":1301778,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-01-16T22:07:43.000Z","date":"2025-01-16","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-25-000684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825000684/doc4.xml","form_type":"4"}},{"id":1301777,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-01-16T22:07:43.000Z","date":"2025-01-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":68.7471,"value":343735.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $68.39 to $69.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-000684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825000684/doc4.xml","form_type":"4"}},{"id":1301776,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2025-01-16T22:07:43.000Z","date":"2025-01-16","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-25-000684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825000684/doc4.xml","form_type":"4"}},{"id":1339474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-12-09T21:58:00.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-010646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010646/doc4.xml","form_type":"4"}},{"id":1339473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-12-09T21:58:00.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":71.7501,"value":358750.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $71.5501 to $71.9850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-010646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010646/doc4.xml","form_type":"4"}},{"id":1339472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-12-09T21:58:00.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-010646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824010646/doc4.xml","form_type":"4"}},{"id":1367153,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-11-13T23:16:03.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-009903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009903/doc4.xml","form_type":"4"}},{"id":1367152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-11-13T23:16:03.000Z","date":"2024-11-13","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":65.5686,"value":327843.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $65.310 to $66.075. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-009903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009903/doc4.xml","form_type":"4"}},{"id":1367151,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-11-13T23:16:03.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-009903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009903/doc4.xml","form_type":"4"}},{"id":1387024,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-10-15T21:03:41.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-009302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009302/doc4.xml","form_type":"4"}},{"id":1387023,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-10-15T21:03:41.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":69.5067,"value":347533.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $69.34 to $69.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-009302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009302/doc4.xml","form_type":"4"}},{"id":1387022,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-10-15T21:03:41.000Z","date":"2024-10-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-009302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824009302/doc4.xml","form_type":"4"}},{"id":1410176,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-09-11T22:06:08.000Z","date":"2024-09-11","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-008604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008604/doc4.xml","form_type":"4"}},{"id":1410175,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-09-11T22:06:08.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":66.7651,"value":333825.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $66.495 to $67.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-008604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008604/doc4.xml","form_type":"4"}},{"id":1410174,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-09-11T22:06:08.000Z","date":"2024-09-11","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-008604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008604/doc4.xml","form_type":"4"}},{"id":1434090,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-08-14T21:58:53.000Z","date":"2024-08-14","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-008015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008015/doc4.xml","form_type":"4"}},{"id":1434089,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-08-14T21:58:53.000Z","date":"2024-08-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":66.084,"value":330420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $65.76 to $66.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-008015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008015/doc4.xml","form_type":"4"}},{"id":1434088,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-08-14T21:58:53.000Z","date":"2024-08-14","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-008015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824008015/doc4.xml","form_type":"4"}},{"id":1457069,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-07-10T21:36:43.000Z","date":"2024-07-10","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-007395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007395/doc4.xml","form_type":"4"}},{"id":1457068,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-07-10T21:36:43.000Z","date":"2024-07-10","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":93.2948,"value":466474.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $92.910 to $93.655. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-007395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007395/doc4.xml","form_type":"4"}},{"id":1457067,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-07-10T21:36:43.000Z","date":"2024-07-10","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-007395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007395/doc4.xml","form_type":"4"}},{"id":1482484,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-06-12T21:19:41.000Z","date":"2024-06-12","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-006780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006780/doc4.xml","form_type":"4"}},{"id":1482483,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-06-12T21:19:41.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":87.5393,"value":437696.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $87.05 to $88.02. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-006780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006780/doc4.xml","form_type":"4"}},{"id":1482482,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-06-12T21:19:41.000Z","date":"2024-06-12","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":51935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-006780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006780/doc4.xml","form_type":"4"}},{"id":1519592,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-13T21:45:49.000Z","date":"2024-05-10","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65500,"derivative":{"exercise_price":45.2767,"exercise_date":"2018-06-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-24-005980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005980/doc4.xml","form_type":"4"}},{"id":1519591,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-13T21:45:49.000Z","date":"2024-05-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":814,"price":86.72,"value":70590.08,"ownership":{"direct":true},"balance_after":46935.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005980/doc4.xml","form_type":"4"}},{"id":1519590,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-13T21:45:49.000Z","date":"2024-05-10","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":87.8076,"value":439038.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $87.415 to $88.050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47749.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005980/doc4.xml","form_type":"4"}},{"id":1519589,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-13T21:45:49.000Z","date":"2024-05-10","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":45.2767,"value":226383.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023."}],"balance_after":52749.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005980/doc4.xml","form_type":"4"}},{"id":1522410,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2024-05-09T23:41:31.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":6700,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001225208-24-005891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005891/doc4.xml","form_type":"4"}},{"id":1522409,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:41:31.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":39600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":39600,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":39600},"source":{"system":"sec-edgar","filing":"0001225208-24-005891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005891/doc4.xml","form_type":"4"}},{"id":1522408,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-09T23:41:31.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":619,"price":85.09,"value":52670.71,"ownership":{"direct":true},"balance_after":47749.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005891/doc4.xml","form_type":"4"}},{"id":1522407,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-09T23:41:31.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":48368.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005891/doc4.xml","form_type":"4"}},{"id":1526662,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2024-05-06T23:16:43.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":5855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":5855},"source":{"system":"sec-edgar","filing":"0001225208-24-005700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005700/doc4.xml","form_type":"4"}},{"id":1526661,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-06T23:16:43.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3475,"price":85.25,"value":296243.75,"ownership":{"direct":true},"balance_after":41668.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005700/doc4.xml","form_type":"4"}},{"id":1526660,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-06T23:16:43.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":5855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":45143.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005700/doc4.xml","form_type":"4"}},{"id":1526659,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-05-06T23:16:43.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":479,"price":85.06,"value":40743.74,"ownership":{"direct":true},"balance_after":39288.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005700/doc4.xml","form_type":"4"}},{"id":1546108,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-04-08T21:10:54.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001225208-24-005004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005004/doc4.xml","form_type":"4"}},{"id":1546107,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-04-08T21:10:54.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":12400,"price":92.3287,"value":1144875.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $91.645 to $92.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39767.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005004/doc4.xml","form_type":"4"}},{"id":1546106,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-04-08T21:10:54.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":100,"price":92.66,"value":9266.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."}],"balance_after":52167.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005004/doc4.xml","form_type":"4"}},{"id":1546105,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-04-08T21:10:54.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":true,"shares":12500,"price":36.75,"value":459375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."}],"balance_after":52267.7184,"source":{"system":"sec-edgar","filing":"0001225208-24-005004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005004/doc4.xml","form_type":"4"}},{"id":1579365,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-03-13T21:44:08.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12500,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001225208-24-004205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004205/doc4.xml","form_type":"4"}},{"id":1579364,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-03-13T21:44:08.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":14500,"price":91.0135,"value":1319695.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $90.65 to $91.44. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39502.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-004205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004205/doc4.xml","form_type":"4"}},{"id":1579363,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-03-13T21:44:08.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":true,"shares":14500,"price":36.75,"value":532875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."}],"balance_after":54002.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-004205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004205/doc4.xml","form_type":"4"}},{"id":1647175,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-02-13T21:51:34.000Z","date":"2024-02-13","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27000,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001225208-24-001949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001949/doc4.xml","form_type":"4"}},{"id":1647174,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-02-13T21:51:34.000Z","date":"2024-02-13","kind":"sale","planned":true,"acquired":false,"shares":10530,"price":85.8094,"value":903572.982,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $85.33 to $86.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39502.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-001949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001949/doc4.xml","form_type":"4"}},{"id":1647173,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-02-13T21:51:34.000Z","date":"2024-02-13","kind":"sale","planned":true,"acquired":false,"shares":470,"price":86.3457,"value":40582.479,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $86.34 to $86.35. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50032.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-001949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001949/doc4.xml","form_type":"4"}},{"id":1647172,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-02-13T21:51:34.000Z","date":"2024-02-13","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":36.75,"value":404250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."}],"balance_after":50502.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-001949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824001949/doc4.xml","form_type":"4"}},{"id":1680272,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-01-12T22:36:26.000Z","date":"2024-01-12","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38000,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001225208-24-000907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000907/doc4.xml","form_type":"4"}},{"id":1680271,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-01-12T22:36:26.000Z","date":"2024-01-12","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":75.67,"value":756700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.41 to $76.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39502.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-000907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000907/doc4.xml","form_type":"4"}},{"id":1680270,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2024-01-12T22:36:26.000Z","date":"2024-01-12","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":36.75,"value":367500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."}],"balance_after":49502.6931,"source":{"system":"sec-edgar","filing":"0001225208-24-000907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824000907/doc4.xml","form_type":"4"}},{"id":1713026,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-12-14T00:04:51.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48000,"derivative":{"exercise_price":36.75,"exercise_date":"2017-06-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001225208-23-011074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011074/doc4.xml","form_type":"4"}},{"id":1713025,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2023-12-14T00:04:51.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":71.86,"value":574880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023."}],"balance_after":39502.6931,"source":{"system":"sec-edgar","filing":"0001225208-23-011074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823011074/doc4.xml","form_type":"4"}}],"next_cursor":"2023-12-14T00:04:51.000000Z,1713025"}